Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 8.2% – Here’s What Happened

Chronological Source Flow
Back

AI Fusion Summary

Adaptive Biotechnologies shares rose 8.2% to $13.84, trading up to $14.04, with volume 437,609. Analysts downgraded to hold; target prices set at $21. COO Julie Rubinstein sold 19,060 shares twice in April, reducing stake by ~4.3%.
15/04 11:15 defenseworld.net
3 Πηγές
15/04 11:58 defenseworld.net
15/04 11:58 defenseworld.net
Comments
Loading...
0